ARO-Pharma is an agent for Chinese manufacturers for APIs, Clean rooms, machines, turnkey projects, and Finished formulations "FDA Approved products" For details, please check APIs page.

Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.

Our initial efforts are focused on discovering and developing Centyrin-oligonucleotide conjugate therapies that are meant to address one of the greatest challenges facing oligonucleotide-based medicines today: targeted delivery of oligonucleotides to extra-hepatic tissues.

Philadelphia, PA, January 9, 2020 – Aro Biotherapeutics Company announces it has entered a licensing and collaboration agreement with Ionis Pharmaceuticals, Inc., the leader in RNA-targeted therapeutics, through which Ionis will use Aro’s CENTYRIN™ technology to develop targeted cell- and tissue- specific delivery of antisense ...

ARO PHARMA PRIVATE LIMITED is a leading and progressive patron healthcare employer with brands which can be advocated by healthcare specialists, and cherished and relied on by way of clients across their existence levels.

Aro-pharma is a Pharmaceuticals, and Healthcare company located in EG with 0 employees. Find top employees, contact details and business statistics at RocketReach.

1 天前 · 目前Arrowhead拥有16款在研产品，其中3款已进入临床III期：ARO-APOC3、ARO-ANG3、Fazirsiran。与武田、 安进 、 葛兰素史克 （GSK）、sarepta四家公司达成超160亿美金的合作开发；有减肥药项目ARO-INHBE，ARO-MMP7；补体ARO-C3，等一系列的超级彩蛋。3款已进入临床III期的药就有高达近50亿的市场...

Since our establishment, ARO-PHARMA managed to establish an excellent reputation in the pharmaceutical industry, which culminated into it becoming an accredited supplier for …

2025年2月11日 · PHILADELPHIA-- (BUSINESS WIRE)-- Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent, targeted short-interfering RNA (siRNA) medicines, today announced that its...

Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform...